Biomedical Engineering Reference
In-Depth Information
141. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Fan CK. Balance of
matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveo-
lar macrophages in cigarette smokers, regulation by interleukin-10. Am J
Respir Crit Care Med 2000; 162:1355-1360.
142. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, et al. Inducible
targeting of IL-13 to the adult lung causes matrix metalloproteinase- and
cathepsin-dependent emphysema. J Clin Invest 2000; 106:1081-1093.
143. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA Jr, et al. Inter-
feron gamma induction of pulmonary emphysema in the adult murine lung. J
Exp Med 2000; 192:1587-1600.
144. van der Pouw Kraan TC, Kucukaycan M, Bakker AM, Baggen JM, van der
Zee JS, Dentener MA, et al. Chronic obstructive pulmonary disease is asso-
ciated with the -1055 IL-13 promoter polymorphism. Genes Immun 2002;
3:436-439.
145. Zhu J, Majumdar S, Qiu Y, Ansari T, Oliva A, Kips JC, et al. Interleukin-4
and interleukin-5 gene expression and inflammation in the mucus-secreting
glands and subepithelial tissue of smokers with chronic bronchitis. Lack
of relationship with CD8
รพ
cells. Am J Respir Crit Care Med 2001; 164:
2220-2228.
146. Prause O, Laan M, Lotvall J, Linden A. Pharmacological modulation of inter-
leukin-17-induced GCP-2-, GRO-a- and interleukin-8 release in human bron-
chial epithelial cells. Eur J Pharmacol 2003; 462:193-198.
147. Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates
with airway hyperresponsiveness to methacholine. Respir Med 2003; 97:
726-733.
148. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, et
al. Transforming growth factor-
b
1 and recruitment of macrophages and mast
cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 1998; 158:1951-1957.
149. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al.
Increased expression of transforming growth factor-
b
1 in small airway epithe-
lium from tobacco smokers and patients with chronic obstructive pulmonary
disease (COPD). Am J Respir Crit Care Med 2001; 163:1476-1483.
150. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M. Increased
production of TGF-
b
and apoptosis of T lymphocytes isolated from periph-
eral blood in COPD. Am J Physiol Lung Cell Mol Physiol 2003; 285:
L492-L499.
151. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacneeW,
et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in
lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 2002; 166:490-495.
152. Ihn H. Pathogenesis of fibrosis: role of TGF-
b
and CTGF. Curr Opin Rheu-
matol 2002; 14:681-685.
153. Ogawa E, Elliott WM, Hughes F, Eichholtz TJ, Hogg JC, Hayashi S. Latent
adenoviral infection induces production of growth factors relevant to airway
remodeling in COPD. Am J Physiol Lung Cell Mol Physiol 2004; 286:
L189-L197.
